Quarterly report pursuant to Section 13 or 15(d)

CONSOLIDATED SCHEDULE OF INVESTMENTS (Parenthetical)

v3.23.3
CONSOLIDATED SCHEDULE OF INVESTMENTS (Parenthetical)
$ in Thousands
Sep. 30, 2023
USD ($)
Dec. 31, 2022
USD ($)
Firm
Investment Holding [Line Items]    
Investment, basis spread, variable rate 8.50% 7.50%
Tax basis of investments, gross, unrealized appreciation $ 97,200 $ 72,200
Tax basis of investments, gross, unrealized depreciation 143,100 112,000
Tax basis of investments, unrealized appreciation (depreciation), net 45,900 39,800
Tax basis of investments, cost for income tax purposes 3,300,000 3,000,000
Investment cost 3,308,894 3,005,696
Investments, at fair value: $ 3,261,391 $ 2,963,955
1-month LIBOR    
Investment Holding [Line Items]    
Interest rate 5.43% 4.40%
3-month LIBOR    
Investment Holding [Line Items]    
Interest rate 5.66% 4.77%
6-month LIBOR    
Investment Holding [Line Items]    
Interest rate 5.90% 5.14%
1-month SOFR    
Investment Holding [Line Items]    
Interest rate 5.32%  
3-month SOFR    
Investment Holding [Line Items]    
Interest rate 5.27%  
6-month SOFR    
Investment Holding [Line Items]    
Interest rate 5.17%  
Common Stock | Quoted Prices in Active Markets for Identical Assets (Level 1)    
Investment Holding [Line Items]    
Number of publicly traded companies | Firm   43
Warrants | Quoted Prices in Active Markets for Identical Assets (Level 1)    
Investment Holding [Line Items]    
Number of publicly traded companies | Firm   27
Phathom Pharmaceuticals, Inc. | Royalty Contract    
Investment Holding [Line Items]    
Investment cost $ 4,600 $ 4,600
Investments, at fair value: 3,200 3,400
Black Crow AI, Inc. affiliates | Promissory Notes [Member]    
Investment Holding [Line Items]    
Principal amount $ 2,400 $ 3,000